相关实验视频
Updated: Jan 7, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.5K
下一篇 - 基因静血纳米粉:纳米凝块安全的理论框架
Malavika Alagirisamy Jayaraman1, Immanuel Devakumar Solomon1
1Independent Researcher.
Acta clinica Belgica
|December 28, 2025
概括
一种新的理论定血剂Nano Clot-SAFE被提议用于创伤和手术中的超快速出血控制. 这项创新旨在克服当前剂的局限性,提供增强的生物相容性和内部使用能力.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 失控出血是创伤和手术环境中死亡的主要原因.
- 目前的止血剂,如高和酸盐,具有显著的局限性,包括热损伤,感染和限制内部应用的风险.
研究的目的:
- 提出一个理论的静血创新,Nano Clot-SAFE,用于快速静血 (≤3秒).
- 为了增强生物相容性,抗菌性质和适用于外部和内部出血情景的可用性.
主要方法:
- 通过对30项同行评审研究的审查,开发了一个概念性表述.
- 拟议的成分包括酸纳米复合物,微孔粉,素功能性纤维素和氧化物纳米颗粒.
- 通过空气喷射或气溶机制的交付以及基于系统的框架的安全考虑被纳入.
主要成果:
- 纳米凝块-SAFE在理论上是为超快速凝块形成 (≤3秒) 设计的.
- 该配方提供耐湿性,抗微生物作用和适应性,用于内部器官的兼容性.
- 综合安全障碍旨在减少用户错误并提高临床性能.
结论:
- 纳米凝块-SAFE是一个概念性的静血框架,具有应急创伤和手术出血控制的潜力.
- 需要进一步的实验验证和临床测试.
- 这一创新表明了手术技术和创伤准备的未来方向.
更多相关视频
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
14.3K
10:12Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
Published on: January 7, 2019
23.4K
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Introduction to Hemostasis
13.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K